(Q40580730)

English

The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

cancer cell line

1 reference

based on heuristic

inferred from title

author name string

Masaki Imai

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hee-Young Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

James S Norris

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Stephen Tomlinson

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

291-297

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

MUC1 in carcinoma-host interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Mapping the active site of CD59

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Modulation of complement gene expression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Fc receptors are required in passive and active immunity to melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Therapeutic intervention with complement and beta-glucan in cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

Human MUC1 mucin: a multifaceted glycoprotein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782423

4 November 2018

The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Mouse strains with typical mammalian levels of complement activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Cytokines affect resistance of human renal tumour cells to complement-mediated injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.0019-2805.2004.01815.X

21 January 2018

Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/15009429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/15009429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.0019-2805.2004.01815.X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40580730&oldid=2146411208"